Literature DB >> 10837195

Granulocyte colony-stimulating factor receptors on granulocytes are down-regulated after endotoxin administration to healthy humans.

P E Dekkers1, N P Juffermans, T t Hove, E de Jonge, S J van Deventer, T van Der Poll.   

Abstract

Granulocyte colony-stimulating factor (G-CSF) is considered an important mediator of host defense against infection, and recombinant G-CSF is administered to patients with various infections. G-CSF binds to a specific receptor that is expressed on granulocytes and monocytes. To obtain insight about the regulation of the G-CSF receptor after an acute infectious challenge, 8 healthy subjects received an intravenous injection of lipopolysaccharide (LPS; 4 ng/kg), and receptor expression was determined on blood leukocytes by fluorescence-activated cell sorter analysis, both by measurement of saturation binding of recombinant G-CSF and by use of an anti-G-CSF-receptor antibody. LPS induced a transient decrease in granulocyte, but not monocyte, G-CSF-receptor expression. In whole blood in vitro, not only LPS but also gram-positive stimuli and proinflammatory cytokines were capable of down-modulating the G-CSF receptor on granulocytes. Bacterial antigens down-regulate the G-CSF receptor at the surface of granulocytes, which may impair neutrophil functions important for antibacterial host defense.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10837195     DOI: 10.1086/315523

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  2 in total

1.  Transcriptomic analysis of human norovirus NS1-2 protein highlights a multifunctional role in murine monocytes.

Authors:  Zabeen Lateef; Gregory Gimenez; Estelle S Baker; Vernon K Ward
Journal:  BMC Genomics       Date:  2017-01-05       Impact factor: 3.969

2.  IFNα enhances the production of IL-6 by human neutrophils activated via TLR8.

Authors:  Maili Zimmermann; Fabio Arruda-Silva; Francisco Bianchetto-Aguilera; Giulia Finotti; Federica Calzetti; Patrizia Scapini; Claudio Lunardi; Marco A Cassatella; Nicola Tamassia
Journal:  Sci Rep       Date:  2016-01-21       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.